The substantial decrease in the phospho-p130Cas level with Crk/CrkL double knockdown in GBM cells is consistent with our previous studies with fibroblasts (51, 52) and colorectal and pancreatic cancer cell lines (42). The gene discussed is CRK; the disease is glioblastoma.